Ncats: service: pharmacokinetic (PK) studies for RXFP1-agonists: severable
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P01622
- Awardee
-
Pharmaron, Inc. UEI L8NQAFSTPSY9
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,296
Award facts
- Opportunity
-
- Pharmacokinetic (PK) studies for RXFP1-agonists Solicitation · 75N98026Q00976 · Posted Aug 7, 2026
- Contract value 100% obligated
- $19,296.00 Current and potential, with all options
- Completion date 10% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences awarded a purchase order to Pharmaron, Inc. for pharmacokinetic studies of RXFP1-agonists on September 14, 2026, with a ceiling value of $19,296.00. Work is performed in Rockville, Maryland. The requirement encompasses in vivo pharmacokinetic studies in male C57BL/6J mice, including single-dose testing of four compounds at 10 mg/kg, plasma and tissue bioanalysis across eight sampling time points, standard PK parameter calculations, and delivery of electronic data files and a final study report. The purchase order is firm fixed-price with an ultimate completion date of September 13, 2027. Pharmaron is a minority-owned contract research organization specializing in preclinical drug development services. The order originated from solicitation 75N98026Q00976, posted August 7, 2026, with responses due August 24, 2026.
Quick answers
Who was awarded contract 75N98026P01622?
75N98026P01622 was awarded to Pharmaron, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 14, 2026.
How much is contract 75N98026P01622 worth?
The government has obligated $19,296 on 75N98026P01622.
Which agency awarded contract 75N98026P01622?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01622, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N98026P01622 competed?
The extent of competition for 75N98026P01622 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award